SARS-CoV-2 Variant Detection

Precision genomic surveillance maps SARS-CoV-2 variants in the Mount Sinai Health System.

MRSA

Methicillin-resistant Staphylococcus aureus outbreak tracking.

Influenza

Tracking the evolution of influenza virus.

Clostridium difficile infections

Understanding spread and dissemination of C. difficile infections.

Our Mission

Precision genomic surveillance of common and emerging pathogens

The Mount Sinai Pathogen Surveillance Program (MS-PSP) applies the latest genomics technologies to track bacterial, viral, and fungal infections in near real-time and provides a framework for tracking and preventing costly nosocomial outbreaks. To this end we have assembled a unique team of experts at the intersection of basic and clinical science, microbiology, genomic sciences, hospital operations, biobanking, genomics, big data analytics, bioinformatics, clinical informatics, biostatistics, computer, computational and data science.

Recent Publications

Mushtaq A and Alburquerque B et al. Clinical, microbiological and genomic characterization of Gram-negative bacteria with dual carbapenemases as identified by rapid molecular testing. JAC Antimicrob Resist. 2023 Dec 30;6(1):dlad137.
Gonzalez-Reiche et al. Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants. Nat Commun. 2023 Jun 3;14(1):3235.